Aleš Maver

2.9k total citations
112 papers, 1.2k citations indexed

About

Aleš Maver is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Aleš Maver has authored 112 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Genetics and 15 papers in Physiology. Recurrent topics in Aleš Maver's work include Genomics and Rare Diseases (22 papers), Genomic variations and chromosomal abnormalities (11 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Aleš Maver is often cited by papers focused on Genomics and Rare Diseases (22 papers), Genomic variations and chromosomal abnormalities (11 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Aleš Maver collaborates with scholars based in Slovenia, Serbia and Croatia. Aleš Maver's co-authors include Borut Peterlin, Alenka Hodžić, Luca Lovrečić, Karin Writzl, Goran Čuturilo, Igor Medica, Eda Vrtačnik Bokal, Ivana Novaković, Marija Volk and Alexander G. Haslberger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Aleš Maver

88 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleš Maver Slovenia 20 506 340 157 139 117 112 1.2k
Kenji Ohe Japan 21 669 1.3× 309 0.9× 82 0.5× 73 0.5× 90 0.8× 74 1.3k
Constance Chen United States 13 530 1.0× 499 1.5× 142 0.9× 162 1.2× 75 0.6× 15 1.5k
Wendy L. Golden United States 25 642 1.3× 393 1.2× 139 0.9× 110 0.8× 67 0.6× 63 1.7k
Jeffrey C. Webster United States 12 394 0.8× 451 1.3× 162 1.0× 83 0.6× 220 1.9× 14 1.2k
Milton R. Brown United States 22 758 1.5× 434 1.3× 120 0.8× 69 0.5× 90 0.8× 41 1.9k
Michelle Moh United States 6 587 1.2× 153 0.5× 312 2.0× 49 0.4× 104 0.9× 14 1.1k
Julia M. Morahan United Kingdom 18 463 0.9× 309 0.9× 118 0.8× 92 0.7× 355 3.0× 35 1.8k
Juan L. Rodríguez-Flores United States 19 432 0.9× 386 1.1× 132 0.8× 48 0.3× 36 0.3× 29 1.1k
Boleslaw Goldman Israel 22 746 1.5× 575 1.7× 193 1.2× 94 0.7× 49 0.4× 74 1.7k
David A. Buchner United States 25 725 1.4× 240 0.7× 273 1.7× 73 0.5× 66 0.6× 44 1.4k

Countries citing papers authored by Aleš Maver

Since Specialization
Citations

This map shows the geographic impact of Aleš Maver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Maver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Maver more than expected).

Fields of papers citing papers by Aleš Maver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Maver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Maver. The network helps show where Aleš Maver may publish in the future.

Co-authorship network of co-authors of Aleš Maver

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Maver. A scholar is included among the top collaborators of Aleš Maver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Maver. Aleš Maver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Božović, Ivana Babič, Annalaura Torella, Mridul Johari, et al.. (2025). Gene prioritisation for enhancing molecular diagnosis in rare skeletal muscle disease cohort. Journal of Medical Genetics. 62(5). 350–357. 1 indexed citations
3.
Maver, Aleš, et al.. (2025). Unraveling the complexity of skeletal dysplasias in the national health system. Frontiers in Endocrinology. 16. 1523737–1523737.
4.
Maver, Aleš, Lluı́s Armengol, Ružica Kravljanac, et al.. (2024). Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability—An Exception or a Necessity?. Genes. 15(6). 789–789.
5.
6.
Rački, Valentino, Anja Kovanda, Nada Starčević Čizmarević, et al.. (2024). GiOPARK Project: The Genetic Study of Parkinson’s Disease in the Croatian Population. Genes. 15(2). 255–255.
7.
Maver, Aleš, et al.. (2024). Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study. Journal of Cardiovascular Translational Research. 18(1). 110–120.
8.
Meglič, Andrej, Marija Volk, Aleš Maver, et al.. (2023). Stargardt-like Clinical Characteristics and Disease Course Associated with Variants in the WDR19 Gene. Genes. 14(2). 291–291.
9.
Ilić, Nikola, et al.. (2023). Sensorineural Hearing Loss in a Child with Succinic Semialdehyde Dehydrogenase Deficiency. SHILAP Revista de lepidopterología. 26(1). 63–68. 1 indexed citations
10.
Maver, Aleš, et al.. (2023). Oral microbiome and preterm birth. Frontiers in Medicine. 10. 1177990–1177990. 9 indexed citations
11.
Meglič, Andrej, Mubeen Khan, Aleš Maver, et al.. (2023). ABCA4 Variant c.5714+5G>A in Trans With Null Alleles Results in Primary RPE Damage. Investigative Ophthalmology & Visual Science. 64(12). 33–33. 1 indexed citations
12.
Kovanda, Anja, Valentino Rački, Dejan Georgiev, et al.. (2022). A multicenter study of genetic testing for Parkinson’s disease in the clinical setting. npj Parkinson s Disease. 8(1). 149–149. 12 indexed citations
13.
Dragašević, Nataša, Valerija Dobričić, Aleš Maver, et al.. (2022). Clinical exome sequencing in Serbian patients with movement disorders: Single centre experience. Genetika. 54(1). 395–409.
14.
Maver, Aleš, Ashraf Yusuf Rangrez, Marijana Ćorić, et al.. (2022). A biallelic loss-of-function variant in MYZAP is associated with a recessive form of severe dilated cardiomyopathy. Molecular Case Studies. 8(5). a006221–a006221. 4 indexed citations
15.
Božović, Ivana Babič, Aleš Maver, Lea Leonardis, et al.. (2021). Diagnostic yield of exome sequencing in myopathies: Experience of a Slovenian tertiary centre. PLoS ONE. 16(6). e0252953–e0252953. 10 indexed citations
16.
Maver, Aleš, et al.. (2021). Children with cavernous malformations of the central nervous system. European Journal of Paediatric Neurology. 35. 61–66. 2 indexed citations
17.
Gualandi, Francesca, Aleš Maver, Serenella Servidei, et al.. (2020). Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study. PLoS ONE. 15(9). e0239329–e0239329. 8 indexed citations
18.
Zaman, Tariq, Ingo Helbig, Ivana Babič Božović, et al.. (2018). Mutations inSCN3Acause early infantile epileptic encephalopathy. Annals of Neurology. 83(4). 703–717. 68 indexed citations
19.
Volk, Marija, Aleš Maver, Alenka Hodžić, Luca Lovrečić, & Borut Peterlin. (2017). Transcriptome Profiling Uncovers Potential Common Mechanisms in Fetal Trisomies 18 and 21. OMICS A Journal of Integrative Biology. 21(10). 565–570. 8 indexed citations
20.
Maver, Aleš, et al.. (2010). The role of chitotriosidase duplication gene polymorphism in the susceptibility to sarcoidosis. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Ohe Breakdown of academic impact, for papers by Constance Chen Breakdown of academic impact, for papers by Wendy L. Golden Breakdown of academic impact, for papers by Jeffrey C. Webster Breakdown of academic impact, for papers by Milton R. Brown Breakdown of academic impact, for papers by Michelle Moh Breakdown of academic impact, for papers by Julia M. Morahan Breakdown of academic impact, for papers by Juan L. Rodríguez-Flores Breakdown of academic impact, for papers by Boleslaw Goldman Breakdown of academic impact, for papers by David A. Buchner
Rankless by CCL
2026